Login to MyKarger

New to MyKarger? Click here to sign up.

Login with Facebook

Forgot Password? Reset your password

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login (Shibboleth)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Table of Contents
Vol. 31, No. 4, 2009
Issue release date: June 2009
Section title: Temperament
Free Access
Dev Neurosci 2009;31:332–341

Consequences of Early Experiences and Exposure to Oxytocin and Vasopressin Are Sexually Dimorphic

Carter C.S.a · Boone E.M.a, c · Pournajafi-Nazarloo H.a · Bales K.L.b
aDepartment of Psychiatry, Brain Body Center, University of Illinois at Chicago, Chicago, Ill., bDepartment of Psychology, University of California, Davis, Calif., and cNational Institute on Drug Abuse, NIH, DHHS, Bethesda, Md., USA
email Corresponding Author

Sue Carter

Department of Psychiatry, Brain Body Center

University of Illinois at Chicago

Chicago, IL 60612 (USA)

Tel. +1 312 355 1593, Fax +1 312 996 7658, E-Mail scarter@psych.uic.edu

Do you have an account?

Login Information

Contact Information

I have read the Karger Terms and Conditions and agree.


In the socially monogamous prairie vole, we have observed that small changes in early handling, as well as early hormonal manipulations can have long-lasting and sexually dimorphic effects on behavior. These changes may be mediated in part by changes in parental interactions with their young, acting on systems that rely on oxytocin (OT) and arginine vasopressin (AVP). Knowledge of both endogenous and exogenous influences on systems that rely on OT and AVP may be helpful in understanding sexually dimorphic developmental disorders, such as autism, that are characterized by increased anxiety and deficits in social behavior.

© 2009 S. Karger AG, Basel

Article / Publication Details

First-Page Preview
Abstract of Temperament

Received: December 16, 2008
Accepted: December 29, 2008
Published online: June 17, 2009
Issue release date: June 2009

Number of Print Pages: 10
Number of Figures: 0
Number of Tables: 2

ISSN: 0378-5866 (Print)
eISSN: 1421-9859 (Online)

For additional information: http://www.karger.com/DNE

Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.